Richard P. Bryce

2018

In 2018, Richard P. Bryce earned a total compensation of $1.9M as B, MRCGP and MFPM Senior Vice President, Clinical Research and Development at Puma Biotechnology, a 40% increase compared to previous year.

Compensation breakdown

Bonus$206,015
Option Awards$657,043
Salary$468,217
Stock Awards$547,650
Other$14,886
Total$1,893,811

Bryce received $657K in option awards, accounting for 35% of the total pay in 2018.

Bryce also received $206K in bonus, $468.2K in salary, $547.7K in stock awards and $14.9K in other compensation.

Rankings

In 2018, Richard P. Bryce's compensation ranked 6,028th out of 14,244 executives tracked by ExecPay. In other words, Bryce earned more than 57.7% of executives.

ClassificationRankingPercentile
All
6,028
out of 14,244
58th
Division
Manufacturing
2,290
out of 5,758
60th
Major group
Chemicals And Allied Products
856
out of 2,119
60th
Industry group
Drugs
716
out of 1,808
60th
Industry
Pharmaceutical Preparations
556
out of 1,382
60th
Source: SEC filing on April 29, 2019.

Bryce's colleagues

We found five more compensation records of executives who worked with Richard P. Bryce at Puma Biotechnology in 2018.

2018

Douglas Hons

Puma Biotechnology

Senior Vice President, Regulatory Affairs, Medical Writing and Project Management

2018

Alan Auerbach

Puma Biotechnology

Chief Executive Officer

2018

Maximo Nougues

Puma Biotechnology

Chief Financial Officer

2018

Steven Lo

Puma Biotechnology

Chief Commercial Officer

2018

Charles Eyler

Puma Biotechnology

Senior Vice President, Finance and Administration

News

You may also like